{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:08:37Z","timestamp":1793196517175,"version":"4.5.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.pharmthera.2005.05.005","type":"journal-article","created":{"date-parts":[[2005,7,6]],"date-time":"2005-07-06T21:15:31Z","timestamp":1120684531000},"page":"294-307","source":"Crossref","is-referenced-by-count":182,"title":["Potassium-competitive acid blockade: A new therapeutic strategy in acid-related diseases"],"prefix":"10.1016","volume":"108","author":[{"given":"Kjell","family":"Andersson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enar","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2005.05.005_bib1","first-page":"A-56","article-title":"Preclinical profile of AZD0865, a novel, selective, potassium-competitive acid blocker","volume":"126","author":"Andersson","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib2","unstructured":"Andersson, K., Hallberg, H., & Holstein, B. (in press). AZD0865, a potassium-competitive acid blocker (P-CAB), does not affect kidney gastric H+,K+-ATPase in the rat. Gut."},{"key":"10.1016\/j.pharmthera.2005.05.005_bib3","doi-asserted-by":"crossref","first-page":"17668","DOI":"10.1074\/jbc.272.28.17668","article-title":"Mutational analysis of putative SCH 28080 binding sites of the gastric H+, K+-ATPase","volume":"272","author":"Asano","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib4","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1074\/jbc.274.11.6848","article-title":"A chimeric gastric H+,K+-ATPase inhibitable with both ouabain and SCH 28080","volume":"274","author":"Asano","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib5","doi-asserted-by":"crossref","first-page":"13968","DOI":"10.1074\/jbc.M308934200","article-title":"The cavity structure for docking the K(+)-competitive inhibitors in the gastric proton pump","volume":"279","author":"Asano","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1043-6618(03)00009-4","article-title":"Histamine in the control of gastric acid secretion: a topic review","volume":"47","author":"Barocelli","year":"2003","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1476-5381.1986.tb09466.x","article-title":"Mechanism of gastric antisecretory effect of SCH 28080","volume":"88","author":"Beil","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.0001-6772.2003.01191.x","article-title":"Identification and regulation of the gastric H+\/K+-ATPase in the rat heart","volume":"179","author":"Beisvag","year":"2003","journal-title":"Acta Physiol Scand"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2005.05.005_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000200917","article-title":"Appropriate acid suppression for the management of gastro-oesophageal reflux disease","volume":"51","author":"Bell","year":"1992","journal-title":"Digestion"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2362.1999.00424.x","article-title":"Effects of spiroglumide, a gastrin receptor antagonist, on acid secretion in humans","volume":"29","author":"Beltinger","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib11","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/bi00060a028","article-title":"Membrane topology and omeprazole labeling of the gastric H+, K(+)-adenosinetriphosphatase","volume":"32","author":"Besancon","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib12","doi-asserted-by":"crossref","first-page":"22438","DOI":"10.1074\/jbc.272.36.22438","article-title":"Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents","volume":"272","author":"Besancon","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1034\/j.1600-0773.2002.910602.x","article-title":"Gastrin agonists and antagonists","volume":"91","author":"Black","year":"2002","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0005-2736(88)90391-4","article-title":"Inhibition of gastric H+\/K+-ATPase by substituted imidazo[1,2-a]pyridines","volume":"946","author":"Briving","year":"1988","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib15","first-page":"A-333","article-title":"Mechanism of action of AZD0865, an H+,K+-ATPase selective, potassium-competitive acid blocker","volume":"126","author":"Briving","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib16","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0002-9270(03)00013-3","article-title":"Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients","volume":"98","author":"Bytzer","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0167-4889(93)90120-E","article-title":"Gastrin action on aminopyrine accumulation in isolated pig parietal cells requires cAMP","volume":"1177","author":"Cabero","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000200992","article-title":"Comparison of once-daily intravenous and oral omeprazole on pentagastrin-stimulated acid secretion in duodenal ulcer patients","volume":"53","author":"Cederberg","year":"1992","journal-title":"Digestion"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib19","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","article-title":"Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis","volume":"112","author":"Chiba","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib20","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1074\/jbc.271.13.7277","article-title":"The rat distal colon P-ATPase alpha subunit encodes a ouabain-sensitive H+, K+-ATPase","volume":"271","author":"Cougnon","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib21","first-page":"29","article-title":"How satisfied are chronic heartburn suffers with their prescription medications? Results of the Patient Unmet Needs Survey","volume":"7","author":"Crawley","year":"2000","journal-title":"J Clin Outcomes Manag"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib22","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00042737-199911000-00016","article-title":"Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion","volume":"11","author":"Dammann","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s004240100609","article-title":"Colocalization of KCNQ1\/KCNE channel subunits in the mouse gastrointestinal tract","volume":"442","author":"Dedek","year":"2001","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib24","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1242\/jcs.115.6.1251","article-title":"Three-dimensional reconstruction of cytoplasmic membrane networks in parietal cells","volume":"115","author":"Duman","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib25","doi-asserted-by":"crossref","first-page":"29617","DOI":"10.1074\/jbc.R100023200","article-title":"Ion pumps in polarized cells: sorting and regulation of the Na+, K+- and H+, K+-ATPases","volume":"276","author":"Dunbar","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-2999(85)90498-4","article-title":"Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug","volume":"112","author":"Eltze","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1476-5381.1982.tb09232.x","article-title":"A study of the inhibitory effects of SCH 28080 on gastric secretion in man","volume":"76","author":"Ene","year":"1982","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib28","first-page":"1371","article-title":"Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?","volume":"83","author":"Fiorucci","year":"1988","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0016-5085(92)90017-S","article-title":"Gastric acidity and gastroesophageal reflux patterns in patients with esophagitis","volume":"103","author":"Fiorucci","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0962-8924(96)81009-9","article-title":"The membrane-recruitment-and-recycling hypothesis of gastric HCl secretion","volume":"6","author":"Forte","year":"1996","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-2952(91)90719-L","article-title":"Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione","volume":"42","author":"Fujisaki","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1113\/jphysiol.2001.013439","article-title":"Specific localization of an inwardly rectifying K(+) channel, Kir4.1, at the apical membrane of rat gastric parietal cells; its possible involvement in K(+) recycling for the H(+)-K(+)-pump","volume":"540","author":"Fujita","year":"2002","journal-title":"J Physiol"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2005.05.005_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1242\/jeb.203.1.107","article-title":"Luminal acidification of diverse organelles by V-ATPase in animal cells","volume":"203","author":"Futai","year":"2000","journal-title":"J Exp Biol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib34","doi-asserted-by":"crossref","first-page":"13737","DOI":"10.1074\/jbc.274.20.13737","article-title":"Stabilization of the H,K-ATPase M5M6 membrane hairpin by K+ ions. Mechanistic significance for p2-type ATPases","volume":"274","author":"Gatto","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib35","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/0016-5085(95)90571-5","article-title":"Turnover of the gastric H+,K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion","volume":"109","author":"Gedda","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib36","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1053\/gast.2001.24053","article-title":"The cardiac K+ channel KCNQ1 is essential for gastric acid secretion","volume":"120","author":"Grahammer","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00365528509089680","article-title":"Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial","volume":"20","author":"Grove","year":"1985","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(83)90114-9","article-title":"Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial","volume":"2","author":"Gustavsson","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/(SICI)1099-081X(1998110)19:8<493::AID-BDD129>3.0.CO;2-Z","article-title":"Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats","volume":"19","author":"Han","year":"1998","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib40","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1021\/bi991396y","article-title":"The carbonyl group of glutamic acid-795 is essential for gastric H+, K+-ATPase activity","volume":"39","author":"Hermsen","year":"2000","journal-title":"Biochemistry"},{"issue":"Suppl 10","key":"10.1016\/j.pharmthera.2005.05.005_bib41","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.14309\/00000434-200410001-00022","article-title":"AZD0865, a potassium-competitive acid blocker (P-CAB), has a long duration of effect in the rat","volume":"99","author":"Holstein","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2005.05.005_bib42","first-page":"S8","article-title":"AZD0865, a potassium-competitive acid blocker (P-CAB), provides predictable inhibition of acid secretion with repeated dosing in the dog","volume":"23","author":"Holstein","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib43","first-page":"A-334","article-title":"AZD0865\u2013a new potassium-competitive acid blocker\u2013exhibits maximal gastric antisecretory effects from first dose","volume":"126","author":"Holstein","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib44","first-page":"A-334","article-title":"Pharmacokinetic and pharmacodynamic profiles of AZD0865, a novel, potassium-competitive acid blocker","volume":"126","author":"Holstein","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/00365529409105369","article-title":"Appropriate acid suppression for optimal healing of duodenal ulcer and gastro-oesophageal reflux disease","volume":"Suppl 201","author":"Howden","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib46","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0006-291X(85)90573-X","article-title":"Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole","volume":"126","author":"Im","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0167-4889(85)90054-0","article-title":"Reversal of antisecretory activity of omeprazole by sulfhydryl compounds in isolated rabbit gastric glands","volume":"845","author":"Im","year":"1985","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib48","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1021\/jm00394a019","article-title":"Antiulcer agents: 3. Structure\u2013activity\u2013toxicity relationships of substituted imidazo[1,2-a]pyridines and a related imidazo[1,2-a]pyrazine","volume":"30","author":"Kaminski","year":"1987","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib49","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1021\/jm00128a005","article-title":"Antiulcer agents: 4. Conformational considerations and the antiulcer activity of substituted imidazo[1,2-a]pyridines and related analogues","volume":"32","author":"Kaminski","year":"1989","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib50","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/0006-2952(88)90586-2","article-title":"SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H++K+)-ATPase","volume":"37","author":"Keeling","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib51","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1016\/S0021-9258(18)83580-3","article-title":"The binding of a K+ competitive ligand, 2-methyl,8-(phenylmethoxy)imidazo(1,2-a)pyridine 3-acetonitrile, to the gastric (H++K+)-ATPase","volume":"264","author":"Keeling","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0006-2952(91)90690-7","article-title":"SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H++K+)-ATPase","volume":"42","author":"Keeling","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib53","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.2042-7158.1998.tb06194.x","article-title":"Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats","volume":"50","author":"Kim","year":"1998","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/bdd.239","article-title":"Pharmacokinetics of a new proton pump inhibitor, YJA-20379-8, after intravenous and oral administration to spontaneously hypertensive rats and DOCA-salt-induced hypertensive rats","volume":"21","author":"Kim","year":"2000","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib55","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1001\/archinte.162.12.1361","article-title":"Willingness to pay for complete symptom relief of gastroesophageal reflux disease","volume":"162","author":"Kleinman","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib56","doi-asserted-by":"crossref","first-page":"16417","DOI":"10.1074\/jbc.M400020200","article-title":"A conformation-specific interhelical salt bridge in the K+ binding site of gastric H,K-ATPase","volume":"279","author":"Koenderink","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib57","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1440-1746.2003.03041.x","article-title":"Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infection","volume":"18","author":"Komazawa","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib58","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1073\/pnas.89.8.3605","article-title":"Expression cloning and characterization of the canine parietal cell gastrin receptor","volume":"89","author":"Kopin","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib59","doi-asserted-by":"crossref","first-page":"F763","DOI":"10.1152\/ajprenal.2001.281.4.F763","article-title":"Detection and localization of H+-K+-ATPase isoforms in human kidney","volume":"281","author":"Kraut","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000028183","article-title":"Differences in pH-dependent activation rates of substituted benzimidazoles and biological in vitro correlates","volume":"56","author":"Kromer","year":"1998","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib61","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000028367","article-title":"Animal pharmacology of reversible antagonism of the gastric acid pump, compared to standard antisecretory principles","volume":"60","author":"Kromer","year":"2000","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1572-0241.2000.01701.x","article-title":"Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration","volume":"95","author":"Lachman","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib63","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1056\/NEJM198403223101205","article-title":"Omeprazole in Zollinger\u2013Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists","volume":"310","author":"Lambers","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib64","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1074\/jbc.275.6.4041","article-title":"Comparison of covalent with reversible inhibitor binding sites of the gastric H, K-ATPase by site-directed mutagenesis","volume":"275","author":"Lambrecht","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib65","article-title":"Identification of the K efflux channel coupled to the gastric H,K ATPase during acid secretion","author":"Lambrecht","year":"2004","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib66","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1021\/jm00014a026","article-title":"Reversible inhibitors of the gastric (H+\/K+)-ATPase: 4. Identification of an inhibitor with an intermediate duration of action","volume":"38","author":"Leach","year":"1995","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib67","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0165-6147(87)90107-6","article-title":"Structure\u2013activity relationships of omeprazole and their mechanism of action","volume":"8","author":"Lindberg","year":"1987","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/med.2610100102","article-title":"Omeprazole: the first proton pump inhibitor","volume":"10","author":"Lindberg","year":"1990","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib69","first-page":"114","article-title":"Gastric antisecretory and cytoprotective activities of SCH 28080","volume":"226","author":"Long","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib70","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.1016\/S0021-9258(19)38807-6","article-title":"Human gastric (H++K+)-ATPase gene. Similarity to (Na++K+)-ATPase genes in exon\/intron organization but difference in control region","volume":"265","author":"Maeda","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib71","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-2999(99)00069-2","article-title":"Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin\/CCK(B) receptor antagonist","volume":"369","author":"Makovec","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.05.005_bib127","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1021\/jm00285a020","article-title":"New thiocarboxamides derivatives with specific gastric antisecretory properties","volume":"14","author":"Malen","year":"1971","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib72","doi-asserted-by":"crossref","first-page":"C191","DOI":"10.1152\/ajpcell.1995.268.1.C191","article-title":"Cloning, functional expression, and characterization of a PKA-activated gastric Cl\u2212 channel","volume":"268","author":"Malinowska","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib73","doi-asserted-by":"crossref","first-page":"C495","DOI":"10.1152\/ajpcell.00386.2003","article-title":"Gastric parietal cell secretory membrane contains PKA- and acid-activated Kir2.1 K+ channels","volume":"286","author":"Malinowska","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib74","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0005-2736(93)90344-Y","article-title":"Characterization of proton transport in bone-derived membrane vesicles","volume":"1146","author":"Mattsson","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib75","first-page":"H1955","article-title":"Evidence of a K(+)-H(+)-ATPase in vascular smooth muscle cells","volume":"262","author":"McCabe","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib76","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1016\/S0021-9258(19)34079-7","article-title":"Interaction of a K(+)-competitive inhibitor, a substituted imidazo[1,2a] pyridine, with the phospho- and dephosphoenzyme forms of H+,K(+)-ATPase","volume":"265","author":"Mendlein","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib77","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/00912700222011562","article-title":"Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study","volume":"42","author":"Metz","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib78","doi-asserted-by":"crossref","first-page":"A311","DOI":"10.1016\/S0016-5085(08)81544-2","article-title":"Pharmacological profiles of Z-360, a novel CCK\/gastrin (CCK2) receptor antagonist with excellent oral potency","volume":"120","author":"Miura","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib79","doi-asserted-by":"crossref","first-page":"A311","DOI":"10.1016\/S0016-5085(08)81545-4","article-title":"Effects of Z-360, a novel CCKB\/gastrin (CCK2) receptor antagonist, on meal-induced acid secretion and experimental ulcer models in dogs and rats","volume":"120","author":"Morita","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib80","doi-asserted-by":"crossref","first-page":"18976","DOI":"10.1016\/S0021-9258(18)55159-0","article-title":"Identification of an extracytoplasmic region of H+,K(+)-ATPase labeled by a K(+)-competitive photoaffinity inhibitor","volume":"266","author":"Munson","year":"1991","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2005.05.005_bib81","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1242\/jeb.203.1.161","article-title":"Analysis of the membrane domain of the gastric H(+)\/K(+)-ATPase","volume":"203","author":"Munson","year":"2000","journal-title":"J Exp Biol"},{"issue":"4 Suppl. 2","key":"10.1016\/j.pharmthera.2005.05.005_bib82","first-page":"A528","article-title":"Tolerability, pharmacokinetics and effects on gastric acid secretion after single oral doses of the potassium-competitive acid blocker AZD0865 in healthy male subjects","volume":"128","author":"Nilsson","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib83","first-page":"1256","article-title":"YM022 [(R)-1-[2,3-dihydro-1-(2\u2032-methylphenacyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin\/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats","volume":"270","author":"Nishida","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 3","key":"10.1016\/j.pharmthera.2005.05.005_bib84","article-title":"The effect of 7 days of dosing with YH1885 on 24-hour intragastric acidity and plasma gastrin concentration in healthy male subjects","volume":"51","author":"Park","year":"2002","journal-title":"Gut"},{"issue":"Suppl VI","key":"10.1016\/j.pharmthera.2005.05.005_bib85","article-title":"Pharmacokinetics of YH1885","volume":"52","author":"Park","year":"2003","journal-title":"Gut"},{"issue":"Suppl VI","key":"10.1016\/j.pharmthera.2005.05.005_bib86","article-title":"The pharmacological properties of a novel acid pump antagonist, YH1885","volume":"52","author":"Park","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib87","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0006-2952(95)02021-7","article-title":"Properties of the reversible, K(+)-competitive inhibitor of the gastric (H+\/K+)-ATPase, SK&F 97574: II. Pharmacological properties","volume":"50","author":"Parsons","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib88","first-page":"1015","article-title":"RP 73870, a gastrin\/cholecystokinin-B receptor antagonist with potent anti-ulcer activity in the rat","volume":"273","author":"Pendley","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib89","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0165-6147(93)90004-4","article-title":"Reversible inhibitors of the gastric H+\/K(+)-transporting ATPase: a new class of anti-secretory agent","volume":"14","author":"Pope","year":"1993","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib90","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1042\/bst0200566","article-title":"Reversible inhibitors of the gastric (H+\/K+)-ATPase as both potential therapeutic agents and probes of pump function","volume":"20","author":"Pope","year":"1992","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib91","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/0006-2952(95)02020-9","article-title":"Properties of the reversible K(+)-competitive inhibitor of the gastric (H+\/K+)-ATPase, SK&F 97574: I. In vitro activity","volume":"50","author":"Pope","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib92","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0016-5085(93)90719-S","article-title":"Histamine secretion from rat enterochromaffinlike cells","volume":"105","author":"Prinz","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib93","first-page":"G663","article-title":"Gastrin effects on isolated rat enterochromaffin-like cells in primary culture","volume":"267","author":"Prinz","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib94","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.ph.52.030190.001541","article-title":"The mechanism and structure of the gastric H,K-ATPase","volume":"52","author":"Rabon","year":"1990","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib95","doi-asserted-by":"crossref","first-page":"8012","DOI":"10.1016\/S0021-9258(18)53057-X","article-title":"Rubidium occlusion within tryptic peptides of the H,K-ATPase","volume":"268","author":"Rabon","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib96","first-page":"G424","article-title":"Differential localization of colonic H(+)-K(+)-ATPase isoforms in surface and crypt cells","volume":"274","author":"Rajendran","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib97","first-page":"G850","article-title":"Characterization of K+ and Cl\u2212 conductances in apical membrane vesicles from stimulated rabbit oxyntic cells","volume":"259","author":"Reenstra","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib98","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bjp.0701864","article-title":"Effect of inhibitors of Na+\/H+-exchange and gastric H+\/K+ ATPase on cell volume, intracellular pH and migration of human polymorphonuclear leucocytes","volume":"124","author":"Ritter","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib99","first-page":"202","article-title":"Proton pump inhibitor attitudes and usage: a patient survey","volume":"27","author":"Robinson","year":"2002","journal-title":"Pharm Ther J"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib100","unstructured":"Rottapharm (2004). CR2945 (Itriglumide) Product profile. Available at: http:\/\/www.rotta.com\/cr2945.htm. Accessed December 17, 2004."},{"key":"10.1016\/j.pharmthera.2005.05.005_bib101","series-title":"Physiology of the Gastrointestinal Tract","first-page":"1119","article-title":"The gastric H+,K+-ATPase","author":"Sachs","year":"1994"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib102","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.pa.35.040195.001425","article-title":"The pharmacology of the gastric acid pump: the H+,K+ ATPase","volume":"35","author":"Sachs","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib103","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-230X-2-17","article-title":"Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials","volume":"2","author":"Salas","year":"2002","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib104","doi-asserted-by":"crossref","first-page":"C685","DOI":"10.1152\/ajpcell.1997.272.2.C685","article-title":"Regulation of colonic H-K-ATPase in large intestine and kidney by dietary Na depletion and dietary K depletion","volume":"272","author":"Sangan","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0006-2952(87)90386-8","article-title":"Studies on the mechanism of action of the gastric microsomal (H++K+)-ATPase inhibitors SCH 32651 and SCH 28080","volume":"36","author":"Scott","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib106","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1046\/j.1365-2036.2000.00822.x","article-title":"Acid suppression in peptic ulcer haemorrhage: a \u2018meta-analysis\u2019","volume":"14","author":"Selby","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib107","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1211\/0022357991777173","article-title":"Biochemical and pharmacological characteristics of a newly synthesized H+\/K+-ATPase inhibitor, YJA20379-8, 3-butyryl-4-[R-1-methylbenzylamino]-8-ethoxy-1,7-naphthyridine, in pigs and rats","volume":"51","author":"Sohn","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib108","first-page":"689","article-title":"Gastrin and gastrin receptor ligands\u2014a review of recent patent literature","volume":"5","author":"Steel","year":"2002","journal-title":"IDrugs"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib109","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1093\/emboj\/17.11.3029","article-title":"Constitutive activation of gastric H+,K+-ATPase by a single mutation","volume":"17","author":"Swarts","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2036.1999.00439.x","article-title":"Effects of S-0509, a novel CCKB\/gastrin receptor antagonist, on acid secretion and experimental duodenal ulcers in rats","volume":"13","author":"Takeuchi","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib111","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1572-0241.2001.03679.x","article-title":"Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease","volume":"96","author":"Tefera","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib112","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1254\/jjp.82.21","article-title":"Studies on the mechanism of action of the gastric H+,K(+)-ATPase inhibitor SPI-447","volume":"82","author":"Tsukimi","year":"2000","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib113","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1254\/jjp.75.303","article-title":"Inhibition of gastric H+, K+-ATPase by 3-amino-5-methyl-2-(2-methyl-3-thienyl)imidazo[1,2-a]thieno[3,2-c]pyridine, SPI-447","volume":"75","author":"Ushiro","year":"1997","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib114","doi-asserted-by":"crossref","first-page":"7480","DOI":"10.1021\/bi0105328","article-title":"Mutational analysis of the K+-competitive inhibitor site of gastric H,K-ATPase","volume":"40","author":"Vagin","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib115","doi-asserted-by":"crossref","first-page":"12755","DOI":"10.1021\/bi025921w","article-title":"SCH28080, a K+-competitive inhibitor of the gastric H,K-ATPase, binds near the M5-6 luminal loop, preventing K+ access to the ion binding domain","volume":"41","author":"Vagin","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib116","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1749-6632.2003.tb07147.x","article-title":"Inhibition kinetics of the gastric H,K-ATPase by K-competitive inhibitor SCH28080 as a tool for investigating the luminal ion pathway","volume":"986","author":"Vagin","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2036.2004.01957.x","article-title":"Review article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease","volume":"19","author":"Vakil","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib118","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1046\/j.1432-1327.2001.02173.x","article-title":"Difference between the E1 and E2 conformations of gastric H+\/K+-ATPase in a multilamellar lipid film system. Characterization by fluorescence and ATR-FTIR spectroscopy under a continuous buffer flow","volume":"268","author":"Vander Stricht","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib119","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1440-1681.1995.tb02332.x","article-title":"Proton and potassium transport by H+\/K(+)-ATPases","volume":"22","author":"van Driel","year":"1995","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002095","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","author":"van Pinxteren","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib121","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1525-1497.2003.20833.x","article-title":"Short-term treatment of gastroesophageal reflux disease","volume":"18","author":"van Pinxteren","year":"2003","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib122","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0021-9258(18)61620-5","article-title":"Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole","volume":"262","author":"Wallmark","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib123","doi-asserted-by":"crossref","first-page":"43197","DOI":"10.1074\/jbc.M104808200","article-title":"A model of reversible inhibitors in the gastric H+\/K+-ATPase binding site determined by rotational echo double resonance NMR","volume":"276","author":"Watts","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib124","first-page":"233","article-title":"Current status of acid pump antagonists (reversible PPIs)","volume":"69","author":"Wurst","year":"1996","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib125","first-page":"474","article-title":"A model of 3D-structure of H+, K+-ATPase catalytic subunit derived by homology modeling","volume":"25","author":"Yan","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pharmthera.2005.05.005_bib126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/0091270003261321","article-title":"Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers","volume":"44","author":"Yu","year":"2004","journal-title":"J Clin Pharmacol"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805001063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805001063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T02:32:07Z","timestamp":1626143527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725805001063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":127,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0163725805001063"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.05.005","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}